Literature DB >> 15914521

High circulating thyrotropin levels in obese women are reduced after body weight loss induced by caloric restriction.

Petra Kok1, Ferdinand Roelfsema, Janneke G Langendonk, Marijke Frölich, Jacobus Burggraaf, A Edo Meinders, Hanno Pijl.   

Abstract

CONTEXT: Previous clinical studies concerning the impact of body weight loss on single plasma TSH concentration measurements or the TSH response to TRH in obese humans have shown variable results.
OBJECTIVE: The objective of this study was to investigate the effect of weight loss induced by caloric restriction on diurnal TSH concentrations and secretion in obese humans.
DESIGN: This was a clinical, prospective, crossover study.
SETTING: The study was conducted at the Clinical Research Center of Leiden University Medical Center. PARTICIPANTS: Eleven obese premenopausal women (body mass index, 33.3 +/- 0.7 kg/m2) were studied. INTERVENTION: The study intervention was weight loss (50% reduction overweight by caloric restriction). MAIN OUTCOME MEASURE(S): Twenty-four-hour plasma TSH concentrations (10-min intervals) and the 24-h TSH secretion rate, calculated by a waveform-independent deconvolution technique (Pulse), were determined.
RESULTS: The 24-h TSH secretion rate was significantly higher in obese women than in normal weight controls, and weight loss was accompanied by diminished TSH release (before weight loss, 43.4 +/- 6.4 mU/liter.24 h; after weight loss, 34.4 +/- 5.9 mU/liter.24 h; P = 0.02). Circulating free T3 levels decreased after weight loss from 4.3 +/- 0.19 to 3.8 +/- 0.14 pmol/liter (P = 0.04). Differences in 24-h TSH release correlated positively with the decline of circulating leptin (r2 = 0.62; P < 0.01).
CONCLUSIONS: Elevated TSH secretion in obese women is significantly reduced by diet-induced weight loss. Among various physiological cues, leptin may be involved in this phenomenon. The decreases in TSH and free T3 may blunt energy expenditure in response to long-term calorie restriction, thereby frustrating weight loss attempts of obese individuals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15914521     DOI: 10.1210/jc.2005-0920

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  30 in total

1.  Levothyroxine absorption in morbidly obese patients before and after Roux-En-Y gastric bypass (RYGB) surgery.

Authors:  Ileana Gabriela Sanchez Rubio; Ana Luiza Galrão; Marco Aurelio Santo; Antonio Carlos Zanini; Geraldo Medeiros-Neto
Journal:  Obes Surg       Date:  2012-02       Impact factor: 4.129

2.  Low Free Triiodothyronine Is Associated with Advanced Fibrosis in Patients at High Risk for Nonalcoholic Steatohepatitis.

Authors:  Paul Manka; Lars Bechmann; Jan Best; Svenja Sydor; Lee C Claridge; Jason D Coombes; Ali Canbay; Lars Moeller; Guido Gerken; Heiner Wedemeyer; Wing-Kin Syn
Journal:  Dig Dis Sci       Date:  2019-06-03       Impact factor: 3.199

Review 3.  Metformin and thyroid: an update.

Authors:  Theodora Pappa; Maria Alevizaki
Journal:  Eur Thyroid J       Date:  2013-01-19

4.  Prevalence of endocrine disorders in morbidly obese patients and the effects of bariatric surgery on endocrine and metabolic parameters.

Authors:  Draženka Janković; Peter Wolf; Christian-Heinz Anderwald; Yvonne Winhofer; Miriam Promintzer-Schifferl; Astrid Hofer; Felix Langer; Gerhard Prager; Bernhard Ludvik; Alois Gessl; Anton Luger; Michael Krebs
Journal:  Obes Surg       Date:  2012-01       Impact factor: 4.129

Review 5.  Effect of Bariatric Surgery on Thyroid Function in Obese Patients: a Systematic Review and Meta-Analysis.

Authors:  Bingsheng Guan; YanYa Chen; Jingge Yang; Wah Yang; Cunchuan Wang
Journal:  Obes Surg       Date:  2017-12       Impact factor: 4.129

6.  Thyroid dysfunction associated with follicular cell steatosis in obese male mice and humans.

Authors:  Min Hee Lee; Jung Uee Lee; Kyong Hye Joung; Yong Kyung Kim; Min Jeong Ryu; Seong Eun Lee; Soung Jung Kim; Hyo Kyun Chung; Min Jeong Choi; Joon Young Chang; Sang-Hee Lee; Gi Ryang Kweon; Hyun Jin Kim; Koon Soon Kim; Seong-Min Kim; Young Suk Jo; Jeongwon Park; Sheue-Yann Cheng; Minho Shong
Journal:  Endocrinology       Date:  2015-01-02       Impact factor: 4.736

Review 7.  Endocrine changes (beyond diabetes) after bariatric surgery in adult life.

Authors:  S Savastano; C Di Somma; R Pivonello; G Tarantino; F Orio; V Nedi; A Colao
Journal:  J Endocrinol Invest       Date:  2013-02-27       Impact factor: 4.256

8.  Absence of thyrotropin-induced increase in leptin levels in patients with history of differentiated thyroid carcinoma undergoing recombinant human thyrotropin testing.

Authors:  F Cecoli; G Andraghetti; C Ghiara; L Briatore; D Cavallero; M Mussap; F Minuto; M Giusti
Journal:  J Endocrinol Invest       Date:  2008-10       Impact factor: 4.256

9.  Dietary iodine absorption is not influenced by malabsorptive bariatric surgery.

Authors:  M Michalaki; S Volonakis; I Mamali; F Kalfarentzos; A G Vagenakis; K B Markou
Journal:  Obes Surg       Date:  2014-11       Impact factor: 4.129

10.  Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass.

Authors:  J Korner; W Inabnet; G Febres; I M Conwell; D J McMahon; R Salas; C Taveras; B Schrope; M Bessler
Journal:  Int J Obes (Lond)       Date:  2009-05-05       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.